Use of tunneled pleural catheters for outpatient treatment of malignant pleural effusions

Current Opinion in Pulmonary Medicine

Volumn 13, Issue 4, 2007, Pages 328-333

  Stather, David Ryan ^a   Tremblay, Alain ^a,b  

^a UNIVERSITY OF CALGARY   (Canada)

^b Health Sciences Centre Calgary   (Canada)

Author keywords

Cancer; Dyspnea; Malignant pleural effusion; Pleurodesis; Tunneled pleural catheters

Indexed keywords

AERATION; CATHETER; CATHETERIZATION; CLINICAL EFFECTIVENESS; HUMAN; INTERMETHOD COMPARISON; MALIGNANT NEOPLASTIC DISEASE; MORBIDITY; MORTALITY; OUTPATIENT CARE; PALLIATIVE THERAPY; PATIENT SAFETY; PLEURA; PLEURA EFFUSION; PLEURODESIS; REVIEW; THORACOSCOPY; TUBE;

AMBULATORY SURGICAL PROCEDURES; CHEST TUBES; EQUIPMENT DESIGN; HUMANS; OUTPATIENTS; PLEURAL EFFUSION, MALIGNANT; THORACOSCOPY; TREATMENT OUTCOME;

EID: 34249812385     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e328121447d     Document Type: Review

References (33)

1. Sahn SA. Malignancy metastatic to the pleura. Clin Chest Med 1998;19:351-361.
2. Ruckdeschel JC. Management of malignant pleural effusion: an overview. Semin Oncol 1988; 15 (3 Suppl 3):24-28.
3. Tremblay A, Michaud G. Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion. Chest 2006; 129:362-368. Analysis of 250 sequential TPC insertions in patients with MPEs in a single center, demonstrating outpatient management with symptom improvement in 88.8% of patients and low complication rates.
4. Bernard A, de Dompsure RB, Hagry O, Favre JP. Early and late mortality after pleurodesis for malignant pleural effusion. Ann Thorac Surg 2002; 74:213-217.
5. Genc O, Petrou M, Ladas G, Goldstraw P. The long-term morbidity of pleuroperitoneal shunts in the management of recurrent malignant effusions. Eur J Cardiothorac Surg 2000; 18:143-146.
6. Petrou M, Kaplan D, Goldstraw P. Management of recurrent malignant pleural effusions: the complementary role of talc pleurodesis and pleuroperitoneal shunting. Cancer 1995; 75:801-805.
7. Diacon AH, Wyser C, Bolliger CT, et al. Prospective randomized comparison of thoracoscopic talc poudrage under local anesthesia versus bleomycin instillation for pleurodesis in malignant pleural effusions. Am J Respir Crit Care Med 2000; 162 (4 Pt 1):1445-1449.
8. Zimmer PW, Hill M, Casey K, et al. Prospective randomized trial of talc slurry vs bleomycin in pleurodesis for symptomatic malignant pleural effusions. Chest 1997; 112:430-434.
9. Dresler CM, Olak J, Herndon JE, et al. Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 2005; 127:909-915.
10. Walker-Renard PB, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 1994; 120:56-64.
11. Lee YC, Baumann MH, Maskell NA, et al. Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists. Chest 2003; 124:2229-2238.
12. Lee YC, Lane KB. The many faces of transforming growth factor-beta in pleural diseases. Curr Opin Pulm Med 2001; 7:173-179.
13. Rehse DH, Aye RW, Florence MG. Respiratory failure following talc pleurodesis. Am J Surg 1999; 177:437-440.
14. West SD, Davies RJ, Lee YC. Pleurodesis for malignant pleural effusions: current controversies and variations in practices. Curr Opin Pulm Med 2004; 10:305-310.
15. Brant A, Eaton T. Serious complications with talc slurry pleurodesis. Respirology 2001; 6:181-185.
16. de Campos JRM, Vargas FS, Werebe EdC, et al. Thoracoscopy talc poudrage: a 15-year experience. Chest 2001; 119:801-806.
17. Bondoc AY, Bach PB, Sklarin NT, Vander Els NJ. Arterial desaturation syndrome following pleurodesis with talc slurry: incidence, clinical features, and outcome. Cancer Invest 2003; 21:848-854.
18. Pollak JSM. Treatment of malignant pleural effusions with tunneled long-term drainage catheters. J Vasc Interv Radiol 2001; 12:201-208.
19. Arapis K, Caliandro R, Stern JB, et al. Thoracoscopic palliative treatment of malignant pleural effusions: results in 273 patients. Surg Endosc 2006; 20:919-923.
20. Yim AP, Chan AT, Lee TW, et al. Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion. Ann Thorac Surg 1996; 62:1655-1658.
21. Management of malignant pleural effusions. Am J Respir Crit Care Med 2000; 162:1987-2001.
22. Antunes G, Neville E, Duffy J, Ali N. BTS guidelines for the management of malignant pleural effusions. Thorax 2003; 58 (Suppl 2):ii29-ii38.
23. Michaud G, Barclay P, Tremblay A. Tunneled pleural catheters for palliation of malignant pleural effusions. J Bronchol 2006; 12:245-248. Detailed description of the TPC system, including TPC insertion and management.
24. Musani AI, Haas AR, Seijo L, et al. Outpatient management of malignant pleural effusions with small-bore, tunneled pleural catheters. Respiration 2004; 71:559-566.
25. Putnam JB Jr, Walsh GL, Swisher SG, et al. Outpatient management of malignant pleural effusion by a chronic indwelling pleural catheter. Ann Thorac Surg 2000; 69:369-375.
26. Putnam JB Jr, Light RW, Rodriguez RM, et al. A randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions. Cancer 1999; 86:1992-1999.
27. Tremblay A, Patel M, Michaud G. Use of tunneled pleural catheters in malignant mesothelioma. J Bronchol 2006; 12:203-206.
28. Neragi-Miandoab S. Malignant pleural effusion, current and evolving approaches for its diagnosis and management. Lung Cancer 2006; 54:1-9.
29. Tan C, Sedrakyan A, Browne J, et al. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur J Cardiothorac Surg 2006; 29:829-838.
30. Lee YC, Light RW. Management of malignant pleural effusions. Respirology 2004; 9:148-156.
31. Bennett R, Maskell N. Management of malignant pleural effusions. Curr Opin Pulm Med 2005; 11:296-300.
32. Pien GW, Gant MJ, Washam CL, Sterman DH. Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion. Chest 2001; 119:1641-1646.
33. Viallat JR, Rey F, Astoul P, Boutin C. Thoracoscopic talc poudragepleurodesis for malignant effusions: a review of 360 cases. Chest 1996; 110:1387-1393.